Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Gynecologic Oncology|November 1, 1990
The impact of whole-abdomen radiotherapy on survival in advanced ovarian cancer patients with minimal residual disease after chemotherapyG Bolis, F Zanaboni, P Vanoli, et al.
Gynecologic Oncology|May 2, 2001
Time since last birth and the risk of ovarian cancerF Chiaffarino, F Parazzini, E Negri, et al.
Radiology|September 1, 1993
Carcinoma of the cervix: value of plain and gadolinium-enhanced MR imaging in assessing degree of invasivenessS Sironi, F De Cobelli, G Scarfone, et al.
Gynecologic Oncology|December 6, 2001
A phase I/II study of topotecan in combination with carboplatin in recurrent epithelial ovarian cancerG Bolis, G Scarfone, C Sciatta, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: clinical results in patients with minimal residual disease of ovarian cancerF Crippa, G Bolis, E Seregni, et al.
Gynecologic Oncology|January 16, 1999
Paclitaxel vs epidoxorubicin plus paclitaxel as second-line therapy for platinum-refractory and -resistant ovarian cancerG Bolis, F Parazzini, G Scarfone, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2006
Epidoxorubicin versus no treatment as consolidation therapy in advanced ovarian cancer: results from a phase II studyG Bolis, S Danese, S Tateo, et al.
Gynecologic Oncology|October 1, 1996
Determinants of response to a cisplatin-based regimen as neoadjuvant chemotherapy in stage IB-IIB invasive cervical cancerG Bolis, I van Zainten-Przybysz, G Scarfone, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Response to second-line weekly cisplatin chemotherapy in ovarian cancer previously treated with a cisplatin- or carboplatin-based regimenG Bolis, G Scarfone, L Luchini, et al.
Cancer|January 1, 1996
Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomyG Bolis, A Villa, P Guarnerio, et al.
Pageof 4